News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
64,522 Results
Type
Article (1463)
Company Profile (19)
Press Release (63040)
Section
Business (28803)
Career Advice (35)
Deals (4140)
Drug Delivery (2)
Drug Development (6504)
Employer Resources (5)
FDA (1302)
Job Trends (1668)
News (39268)
Policy (2248)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (165)
Accelerated approval (2)
Adcomms (1)
Allergies (14)
Alliances (2609)
ALS (24)
Alzheimer's disease (106)
Antibody-drug conjugate (ADC) (30)
Approvals (1399)
Artificial intelligence (42)
Autoimmune disease (25)
Automation (7)
Bankruptcy (17)
Best Places to Work (1634)
BIOSECURE Act (1)
Biosimilars (11)
Biotechnology (20)
Bladder cancer (32)
Brain cancer (5)
Breast cancer (68)
Cancer (650)
Cardiovascular disease (46)
Career advice (34)
Career pathing (2)
CAR-T (18)
Cell therapy (65)
Cervical cancer (9)
Clinical research (6247)
Collaboration (112)
Compensation (79)
Complete response letters (2)
COVID-19 (182)
CRISPR (6)
C-suite (45)
Cystic fibrosis (23)
Data (924)
Depression (14)
Dermatology (6)
Diabetes (60)
Diagnostics (734)
Digital health (5)
Diversity, equity & inclusion (1)
Drug discovery (28)
Drug pricing (6)
Duchenne muscular dystrophy (18)
Earnings (26582)
Employer branding (1)
Employer resources (4)
Events (6418)
Executive appointments (32)
FDA (1829)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (7)
Funding (85)
Gene editing (15)
Generative AI (3)
Gene therapy (55)
GLP-1 (71)
Government (247)
Guidances (249)
Healthcare (1912)
HIV (23)
Huntington's disease (2)
IgA nephropathy (6)
Immunology and inflammation (30)
Immuno-oncology (6)
Indications (23)
Infectious disease (206)
Inflammatory bowel disease (16)
Influenza (4)
Intellectual property (31)
Interviews (1)
IPO (3009)
IRA (1)
Job creations (126)
Job search strategy (31)
JPM (2)
Kidney cancer (1)
Labor market (4)
Layoffs (24)
Legal (442)
Liver cancer (9)
Lung cancer (148)
Lymphoma (91)
Machine learning (4)
Management (1)
Manufacturing (40)
MASH (36)
Medical device (1693)
Medtech (1698)
Mergers & acquisitions (1207)
Metabolic disorders (142)
mRNA (5)
Multiple sclerosis (35)
NASH (2)
Neurodegenerative disease (20)
Neuropsychiatric disorders (8)
Neuroscience (244)
NextGen: Class of 2026 (564)
Non-profit (196)
Obesity (42)
Opinion (3)
Ovarian cancer (19)
Pain (13)
Pancreatic cancer (15)
Parkinson's disease (23)
Partnered (3)
Patents (43)
Patient recruitment (36)
Peanut (3)
People (2198)
Pharmaceutical (4)
Pharmacy benefit managers (2)
Phase 1 (1283)
Phase 2 (2405)
Phase 3 (2821)
Pipeline (1756)
Policy (8)
Postmarket research (354)
Preclinical (443)
Press Release (1)
Prostate cancer (17)
Psychedelics (4)
Radiopharmaceuticals (21)
Rare diseases (92)
Real estate (302)
Recruiting (2)
Regulatory (1935)
Reports (11)
Research institute (125)
Resumes & cover letters (2)
Rett syndrome (4)
RSV (9)
Schizophrenia (14)
Series A (11)
Series B (4)
Service/supplier (2)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (10)
Sponsored (2)
Startups (122)
Stomach cancer (2)
Supply chain (4)
Tariffs (1)
Vaccines (62)
Venture capital (6)
Weight loss (25)
Women's health (8)
Worklife (1)
Date
Last 7 days (95)
Last 30 days (352)
Last 365 days (3818)
2026 (978)
2025 (3907)
2024 (4525)
2023 (5271)
2022 (5641)
2021 (6370)
2020 (5555)
2019 (4553)
2018 (3326)
2017 (3036)
2016 (2130)
2015 (2723)
2014 (1986)
2013 (1351)
2012 (1390)
2011 (1698)
2010 (1641)
Location
Africa (41)
Alabama (3)
Alaska (1)
Arizona (41)
Asia (3518)
Australia (333)
California (1515)
Canada (622)
China (137)
Colorado (80)
Connecticut (57)
Delaware (46)
Europe (10873)
Florida (228)
Georgia (72)
Idaho (3)
Illinois (88)
India (3)
Indiana (96)
Japan (48)
Kansas (7)
Kentucky (4)
Louisiana (12)
Maine (26)
Maryland (158)
Massachusetts (960)
Michigan (36)
Minnesota (91)
Missouri (12)
Montana (3)
Nebraska (1)
Nevada (17)
New Hampshire (10)
New Jersey (577)
New York (388)
North Carolina (142)
Northern California (896)
Ohio (24)
Oklahoma (1)
Oregon (1)
Pennsylvania (289)
Rhode Island (1)
South America (67)
South Carolina (1)
Southern California (514)
Tennessee (19)
Texas (206)
United States (5249)
Utah (49)
Virginia (14)
Washington D.C. (6)
Washington State (126)
Wisconsin (9)
64,522 Results for "77".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
R1 Leads Busy Fundraising Day With $77.5M Series A Raise for Kidney Disease
Alongside R1 Therapeutics, Mestag Therapeutics and iDEL Therapeutics also brought in money on Tuesday, helping to push their respective cancer portfolios forward.
March 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Crossbow Therapeutics Raises $77 Million in Series B Financing to Advance Development of TCR-mimetic Antibody Therapies to Treat Cancer
March 18, 2026
·
6 min read
Press Releases
BoomRx Surpasses $15.5 Million in Net Order Revenue and 77,000+ Processed Orders in First Eight Months
March 4, 2026
·
3 min read
Press Releases
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease
March 17, 2026
·
11 min read
Press Releases
Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital
December 17, 2025
·
6 min read
Press Releases
Hoth Therapeutics Reports Positive HT-001 PK, Safety, and Clinical Activity Data in Cancer Patients with EGFR Therapy-Associated Skin Toxicities Showing ~77% Increase in Drug Exposure and Minimal Systemic Absorption
March 24, 2026
·
6 min read
Press Releases
Compounding Pharmacy Market Size Worth USD 31.77 Bn by 2034 Personalized Medicine Demand Accelerates
December 9, 2025
·
1 min read
Press Releases
PAQ Therapeutics Announces Series B Extension, Bringing Total Series B Financing to $77 Million; First Patient Dosed in Phase 1 Trial of PT0511, a Pan-KRAS Degrader
January 22, 2026
·
2 min read
Press Releases
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
November 14, 2025
·
11 min read
Press Releases
Sai Life Sciences Limited Reports Revenue growth of 77% YoY
August 8, 2025
·
5 min read
1 of 6,453
Next
